These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25616856)

  • 21. Chemotherapy in metastatic colorectal cancer.
    Christopoulou A
    Tech Coloproctol; 2004 Nov; 8 Suppl 1():s43-6. PubMed ID: 15655639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tenth anniversary of bevacizumab in colorectal cancer: has it fulfilled its promise?
    Salazar R; Grasselli J; Santos C; Tabernero J
    Future Oncol; 2014 Feb; 10(2):149-52. PubMed ID: 24490598
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemotherapy in metastatic colorectal cancer.
    Kelly C; Cassidy J
    Surg Oncol; 2007 Jul; 16(1):65-70. PubMed ID: 17521906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of advanced colorectal and gastric cancer with 5-fluorouracil and calcium n-methyltetrahydrofolate.
    Casali A; Tonachella R; Tropea F; Verri C; Paoletti G; Gionfra T; Modugno G; Gallo Curcio C
    J Chemother; 1989 Jul; 1(4 Suppl):1212-4. PubMed ID: 16312838
    [No Abstract]   [Full Text] [Related]  

  • 25. Progression-free survival in bevacizumab-based first-line treatment for patients with metastatic colorectal cancer: is it a really good end point?
    Montagnani F; Migali C; Fiorentini G
    J Clin Oncol; 2009 Oct; 27(28):e132-3; author reply e134-5. PubMed ID: 19720898
    [No Abstract]   [Full Text] [Related]  

  • 26. First-line treatment options for patients with metastatic colorectal cancer.
    Schilsky RL
    Nat Clin Pract Oncol; 2004 Dec; 1(2):70-1. PubMed ID: 16264820
    [No Abstract]   [Full Text] [Related]  

  • 27. Cetuximab in the treatment of colorectal cancer.
    Goldberg RM; Venook AP; Schilsky RL
    Clin Adv Hematol Oncol; 2004 Nov; 2(11):1-10; quiz 11-12. PubMed ID: 16170891
    [No Abstract]   [Full Text] [Related]  

  • 28. Usefulness of monthly chemotherapy for patients with unresectable metastatic colorectal cancer.
    Tomoda M; Kawahara H; Watanabe K; Enomoto H; Akiba T; Yanaga K
    Anticancer Res; 2014 Jan; 34(1):191-4. PubMed ID: 24403461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use cetuximab after oxaliplatin-based chemotherapy in a patient with metastatic colorectal cancer.
    Malik Z; Eng C
    Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):4-7. PubMed ID: 17491584
    [No Abstract]   [Full Text] [Related]  

  • 30. An increasingly common challenge: management of the complete responder with multi-focal metastatic colorectal cancer.
    Schrag D; Weiser M; Schattner M; Shia J; Akhurst T
    J Clin Oncol; 2005 Mar; 23(9):1799-802. PubMed ID: 15774773
    [No Abstract]   [Full Text] [Related]  

  • 31. Maintenance therapy in metastatic colorectal cancer.
    Marshall JL
    Clin Adv Hematol Oncol; 2014 Jun; 12(6):388-90. PubMed ID: 25003569
    [No Abstract]   [Full Text] [Related]  

  • 32. Multi-center phase II study of FLOX for advanced colorectal cancer patients in Japan: SWIFT 3 study.
    Kato T; Nagata N; Fujii M; Takemoto H; Kondo K; Okuyama Y; Tominaga H; Sakamoto J; Mishima H
    Anticancer Res; 2011 Dec; 31(12):4657-64. PubMed ID: 22199346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Adjuvant chemotherapy after curative surgery for non-metastatic colorectal carcinomas (2-year results of 52 cases)].
    Boussen H; Kallel N; Khomsi F; Jerbi G; Dhouib R; Ben Safta Z; Ben Abdesselem M; el May M; Gammoudi A; Benna F; Hamza H; Dziri C; Najah N; Zaouche A; Rahal K; Ben Ayed F
    Tunis Med; 1999 Feb; 77(2):61-7. PubMed ID: 10333701
    [No Abstract]   [Full Text] [Related]  

  • 34. When to use triplet chemotherapy as first-line treatment in metastatic colorectal cancer.
    Cremolini C
    Clin Adv Hematol Oncol; 2019 Aug; 17(8):433-435. PubMed ID: 31449510
    [No Abstract]   [Full Text] [Related]  

  • 35. The management of colorectal cancer: chemotherapy.
    Ross PJ; Cunningham D
    Crit Rev Oncol Hematol; 1999 May; 30(3):215-26. PubMed ID: 10439067
    [No Abstract]   [Full Text] [Related]  

  • 36. Methodologic diligence is needed to define and validate tumor-size response metrics to predict overall survival in first-line metastatic colorectal cancer.
    Mansmann UR; Laubender RP
    J Clin Oncol; 2013 Dec; 31(34):4373-4. PubMed ID: 24166531
    [No Abstract]   [Full Text] [Related]  

  • 37. Is there a standard chemotherapeutic strategy in colorectal cancer?
    Zaniboni A; Meriggi F; Rizzi A; Mutti S; Morandi G
    Crit Rev Oncol Hematol; 1999 May; 30(3):229-38. PubMed ID: 10439068
    [No Abstract]   [Full Text] [Related]  

  • 38. RE: Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer.
    van Erning FN; Elferink MA; Bos AC; Lemmens VE
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26389156
    [No Abstract]   [Full Text] [Related]  

  • 39. RE: Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer.
    He WZ; Xia LP
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26376497
    [No Abstract]   [Full Text] [Related]  

  • 40. Response.
    Cremolini C; Loupakis F; Lenz HJ
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26389154
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.